http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0546591-A3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-002 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
filingDate | 1992-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1994-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0546591-A3 |
abstract | The present invention relates to 11 beta -substituted 14,17-ethanoestratrienes of the general formula I <IMAGE> in which R<1> is a hydrogen atom, a C1-C12-alkanoyl, a benzoyl, a straight-chain or branched C1-C12-alkyl, a C3-C7-cycloalkyl or a C4-C8-alkylcycloalkyl group, R<2> is a hydrogen atom or a C1-C12-alkanoyl group and R<3> is a group <IMAGE> where n is 0, 1 or 2, and R<4> and R<5> independently of one another are a hydrogen atom or a straight-chain or branched C1-C8-alkyl group, which can also be partly fluorinated, to a process for the preparation thereof, to the pharmaceutical products containing these compounds, and to the use thereof for producing medicines. |
priorityDate | 1991-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.